| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 229.484 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 193.513 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 176.704 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 254.897 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 139.398 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 139.108 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 163.963 | 81 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 240.565 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 256.569 | 86 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 174.18 | 82 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 187.122 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 157.979 | 81 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 311.935 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 229.484 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 190.436 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 258.667 | 86 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 221.463 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 227.725 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 172.981 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 276.396 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 208.051 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 218.298 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 186.45 | 83 |